Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.

Authors: Smit, JJ  Schinkel, AH  Oude Elferink, RP  Groen, AK  Wagenaar, E  Van Deemter, L  Mol, CA  Ottenhoff, R  Van der Lugt, NM  Van Roon, MA 
Citation: Smit JJ, etal., Cell 1993 Nov 5;75(3):451-62.
Pubmed: (View Article at PubMed) PMID:8106172

Two types of P-glycoprotein have been found in mammals: the drug-transporting P-glycoproteins and a second type, unable to transport hydrophobic anticancer drugs. The latter is encoded by the human MDR3 (also called MDR2) and the mouse mdr2 genes, and its tissue distribution (bile canalicular membrane of hepatocytes, B cells, heart, and muscle) suggests a specialized metabolic function. We have generated mice homozygous for a disruption of the mdr2 gene. These mice develop a liver disease that appears to be caused by the complete inability of the liver to secrete phospholipid into the bile. Mice heterozygous for the disrupted allele had no detectable liver pathology, but half the level of phospholipid in bile. We conclude that the mdr2 P-glycoprotein has an essential role in the secretion of phosphatidylcholine into bile and hypothesize that it may be a phospholipid transport protein or phospholipid flippase.


Disease Annotations
Objects Annotated

Additional Information

RGD Object Information
RGD ID: 1300325
Created: 2004-07-20
Species: All species
Last Modified: 2004-07-20
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.